MEGAN M ASH

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant BATTLE CREEK, MI NPI 1720518657

General Payments — all program years on this page

$1,686.79

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 90
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $424.86 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $424.8621

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $321.3517
2022 $373.4323
2023 $567.1529
2024 $424.8621

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086335209 Bayer Healthcare Pharmaceuticals Inc. $17.82 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086773241 Novartis Pharmaceuticals Corporation $14.05 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100432455 Novo Nordisk Inc $24.27 04/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100512711 Novo Nordisk Inc $20.81 03/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100652253 Novo Nordisk Inc $22.61 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105629542 AstraZeneca Pharmaceuticals LP $14.23 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118128815 Boehringer Ingelheim Pharmaceuticals, Inc. $20.20 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119018290 Otsuka America Pharmaceutical, Inc. $20.99 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131039279 PFIZER INC. $20.10 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131258479 PFIZER INC. $23.76 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131441390 PFIZER INC. $23.63 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131886383 PFIZER INC. $21.78 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135842158 Lilly USA, LLC $14.41 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139489690 Astellas Pharma US Inc $21.59 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139496202 Astellas Pharma US Inc $19.24 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139502098 Astellas Pharma US Inc $18.83 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139510429 Astellas Pharma US Inc $20.75 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144634769 Xeris Pharmaceuticals, Inc. $23.18 08/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144634771 Xeris Pharmaceuticals, Inc. $22.44 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144634773 Xeris Pharmaceuticals, Inc. $16.85 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145989644 Lundbeck LLC $23.32 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.